Awards & Advancement

Synthetic Biologics appoints Carol Reed as senior vice president

Thursday, May 17, 2012 11:12 AM

Synthetic Biologics, an Ann Arbor, Mich.-based developer of synthetic DNA-based therapeutics and disease-modifying medicines for serious illnesses, has appointed Carol Reed, M.D., as senior vice president of clinical & regulatory affairs.

More... »

Insmed appoints Hayden, Jr. as executive chairman

Thursday, May 17, 2012 10:45 AM

Insmed, a Monmouth Junction, N.J.-based biopharmaceutical company focused on inhalants, has appointed Donald J. Hayden, Jr. as executive chairman of the company's board of directors.

More... »

Medivir appoints Juserius commercial executive vice president

Thursday, May 17, 2012 10:44 AM

Medivir, a Stockholm-based specialty pharmaceutical company focused on infectious diseases, has appointed Henric Juserius to head the company's commercial activities.

More... »

Creabilis appoints Simon Russell as chief business officer

Friday, May 4, 2012 04:43 PM

Creabilis, a European biotech specializing in the development of treatments for dermatology, inflammation and pain, has appointed Simon Russell as chief business officer.

More... »

GSK adds two non-executive directors to its board

Friday, May 4, 2012 08:00 AM

GlaxoSmithKline (GSK) has appointed Lynn Elsenhans and Jing Ulrich as non-executive directors to the company’s board, beginning July 1, 2012.

More... »

Covance announces executive appointments

Friday, May 4, 2012 04:08 AM

Covance, a Princeton, N.J.-based provider of drug development services, has promoted Bill Klitgaard to corporate senior vice president and chief information officer, and Alison Cornell to corporate vice president and chief financial officer, effective May 8 upon approval by the board of directors.

More... »

Regulus Therapeutics appoints Bruce Carter to board of directors

Wednesday, May 2, 2012 04:38 PM

Regulus Therapeutics, a biopharmaceutical company focused on medicines targeting microRNAs, has appointed Bruce Carter, Ph.D., to its board of directors.

More... »

NIH awards ImmuVen $1.68 million grant

Wednesday, May 2, 2012 11:54 AM

ImmuVen, a biotech based in Champaign, Ill., was awarded a phase II Small Business Innovation Research (SBIR) grant totaling $1.68 million from the National Institute for Allergy and Infectious Disease.

More... »

Benchmark Research wins ViE Award for best clinical trial site

Tuesday, May 1, 2012 11:03 AM

Benchmark Research’s Austin, Texas location was recognized as Best Clinical Trial Site at the 2012 Vaccine Industry Excellence (ViE) Awards, held during the Annual World Vaccine Congress.

More... »

Recipients of 2012 SAFE-Biopharma Digi Award named

Monday, April 30, 2012 04:52 PM

Recipients have been selected for the 2012 SAFE-BioPharma Digi Award, recognizing innovative uses of the global SAFE-BioPharma digital identity and digital signature standard and the institutions and individuals contributing to broader understanding of its benefits. Recipients included: Astellas, Bristol-Myers Squibb and representatives of two U.S. government entities.

More... »